Automated Cell Culture Market Strategic Analysis of Emerging Applications
The global automated cell culture market size was estimated at USD 21.4 billion in 2025 and is projected to reach USD 56.1 billion by 2033, growing at a CAGR of 13.2% from 2025 to 2033. This growth is being fueled by the increasing need for scalable and highly reproducible cell-based processes across research, biopharmaceutical manufacturing, regenerative medicine, and drug development applications. As laboratories and production facilities seek to improve throughput, reduce manual intervention, and maintain consistent culture conditions, the adoption of automated systems continues to accelerate. Ongoing advancements in robotics, artificial intelligence, and integrated software platforms are further enhancing the efficiency, precision, and reliability of automated cell culture workflows, thereby supporting the sustained expansion of the market over the forecast period.
Key Market Trends & Insights
• The North America automated cell culture market held the largest share of the global industry in 2025, accounting for 48.3% of total revenue. The region’s leadership is supported by its advanced healthcare and life sciences infrastructure, significant investments in biotechnology research, strong presence of pharmaceutical and biopharmaceutical manufacturers, and widespread adoption of laboratory automation technologies across academic and commercial settings.
• The U.S. automated cell culture industry is expected to witness substantial growth over the forecast period due to the expanding aging population. As the number of elderly individuals continues to rise, the demand for advanced therapeutics, regenerative medicine, and biologics is increasing, encouraging greater use of automated cell culture systems to enhance production efficiency, consistency, and scalability.
• Based on product type, the instruments segment dominated the market in 2025. This segment includes automated incubators, liquid handling systems, robotic arms, and integrated culture platforms that play a critical role in reducing manual intervention, minimizing contamination risk, and ensuring standardized cell culture conditions for research and manufacturing applications.
• Based on application, the biopharmaceutical production segment dominated the market with a share of 43.6% in 2025. The segment’s leading position is attributed to the growing reliance on automated cell culture technologies in the production of monoclonal antibodies, vaccines, recombinant proteins, and cell and gene therapies, all of which require highly controlled and reproducible cell growth environments.
• Based on end user, the pharmaceutical & biotech companies segment dominated the market with a revenue share of 52.7% in 2025. These companies are increasingly adopting automated cell culture solutions to accelerate drug discovery, improve process development, optimize large-scale manufacturing, and maintain strict regulatory and quality standards across their operations.
Looking for more specific insights? Customize this report to suite your business needs
Key Automated Cell Culture Company Insights
The automated cell culture industry is moderately consolidated, with several established life sciences and laboratory technology companies accounting for a significant share of overall revenue. Leading players such as Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA, and Corning Incorporated collectively maintain strong positions in the industry. Their leadership is supported by broad product portfolios, extensive global distribution networks, well-established customer relationships, and continuous investments in research and development. These companies offer integrated solutions that combine automated instruments, specialized consumables, reagents, and advanced software platforms, enabling users to streamline workflows and improve the consistency and scalability of cell culture operations. By delivering comprehensive end-to-end solutions, they continue to strengthen their competitive standing and expand their presence across research, clinical, and manufacturing applications.
Other important participants, including Lonza Group, Becton, Dickinson and Company, Eppendorf SE, Tecan Group, and Agilent Technologies, contribute to the industry through specialized expertise in cell processing, laboratory automation, liquid handling, and analytical systems. These companies play an important role in addressing specific research and production requirements by offering innovative technologies tailored to academic institutions, contract research organizations, and biopharmaceutical manufacturers. The competitive landscape is characterized by continuous product innovation, strategic partnerships, acquisitions, and collaborations aimed at expanding technological capabilities and enhancing automation across the entire cell culture workflow. In addition, many companies are focused on developing fully integrated platforms that improve efficiency, reduce contamination risk, and support high-throughput, reproducible cell-based processes.
Key Automated Cell Culture Companies:
The following key companies have been profiled for this study on the automated cell culture market.
• Thermo Fisher Scientific
• Danaher Corporation
• Sartorius AG
• Merck KGaA
• Lonza Group
• Becton, Dickinson and Company (BD)
• Corning Incorporated
• Eppendorf SE
• Tecan Group
• Agilent Technologies
Grand View Research offers
√ Focused market intelligence reports on specific geographies or high-growth segments.
√ Extended forecast timelines for long-term planning.
√ Competitor Benchmarking and Supply Chain Analysis
√ Inclusion of regulatory and policy assessments.
√ Inclusion of custom data models, KPIs, or applications unique to your business
√ Specific high-impact Data Decks and Tables to support effective decision making
And much more…
Looking for a report customized to your requirements? Explore our Custom Research Offering
Comments
Post a Comment